MedTrace Logo

Valsartan in Elderly Isolated Systolic Hypertension Study

NCT00151229 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3079

Last updated 2015-06-04

No results posted yet for this study

Summary

The aim of this study is to compare the incidence of cardiovascular events between two target systolic blood pressure levels, below 140 mmHg and below 150 mmHg under treatment with valsartan in elderly isolated systolic hypertensive patients in Japan.

Conditions

  • Aged
  • Systolic Hypertension

Interventions

OTHER

target blood pressure

Sponsors & Collaborators

  • Japan Cardiovascular Research Foundation

    collaborator OTHER

  • VALISH study

    lead OTHER

Principal Investigators

  • Toshio Ogihara, MD, PhD · Department of Geriatric Medicine, Osaka University Graduate School of Medicine

  • Takao Saruta, MD, PhD · Department of Internal Medicine, Keio University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00151229 on ClinicalTrials.gov